These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. Henriksen PA; Hitt M; Xing Z; Wang J; Haslett C; Riemersma RA; Webb DJ; Kotelevtsev YV; Sallenave JM J Immunol; 2004 Apr; 172(7):4535-44. PubMed ID: 15034071 [TBL] [Abstract][Full Text] [Related]
10. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages. Sano C; Shimizu T; Tomioka H Cytokine; 2003 Jan; 21(1):38-42. PubMed ID: 12668158 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Jaffray C; Yang J; Carter G; Mendez C; Norman J Surgery; 2000 Aug; 128(2):225-31. PubMed ID: 10922996 [TBL] [Abstract][Full Text] [Related]
12. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Lentsch AB; Czermak BJ; Bless NM; Van Rooijen N; Ward PA Am J Respir Cell Mol Biol; 1999 Apr; 20(4):692-8. PubMed ID: 10101001 [TBL] [Abstract][Full Text] [Related]
13. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. Lentsch AB; Shanley TP; Sarma V; Ward PA J Clin Invest; 1997 Nov; 100(10):2443-8. PubMed ID: 9366558 [TBL] [Abstract][Full Text] [Related]